De Gruyter
Open Medicine
(ISSN 2391-5463)
About this journal
Open Medicine is a journal that provides free, instant, and continued access to all content worldwide. The journal's primary goal is to maintain the high quality of its published content with a strong focus on translational research. Its mission is to facilitate the exchange of ideas between biomedical researchers from different disciplines and countries. Papers connected to all fields of medicine and public health are welcomed. Open Medicine accepts submissions of research articles, reviews, case reports, letters to the editor and book reviews.
The journal aims to promote knowledge directly relevant to all fields of biomedical science. Subject areas suitable for publication include, but are not limited to, the following:
Anesthesiology, Cardiology, Clinical Microbiology and Infectious Diseases, Dental Medicine, Dermatology, Endocrinology, Gastroenterology, Gynecology, Immunology, Internal Medicine, Otolaryngology, Nephrology, Neurology, Oncology, Ophthalmology, Orthopedics, Pediatric and Neonatology, Public health, Surgery, and Urology.
Open Medicine also publishes original work in Medical Genetics, Molecular and Experimental Medicine. Early molecular explorations and implementation research of innovations with high technology readiness are brought together in the journal.
Why submit
As an Author of Open Medicine, You benefit from
fast, fair and constructive peer review
immediate publication of articles
language-correction services for authors from non-English speaking regions
no limitations on colour figures and word count in published articles
free availability to everyone, anywhere in the world
extensive promotion of all articles
distribution to open access directories (such as DOAJ) and thousands of libraries worldwide
authors retain copyright to their work
secure archiving by De Gruyter and the independent archiving service Portico
Topical/Special Issues:
Computational Intelligence Methodologies Meets Recurrent Cancers
Clinical and Research value of Cancer Stem Cells
Linking Pathobiological Mechanisms to Clinical Application for cardiovascular diseases